MarketCapTrends
MCRB

Seres Therapeutics, Inc. (MCRB)

NASDAQ · Healthcare

Seres Therapeutics, Inc. annual/quarterly total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Seres Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 94.0M, a 25.43% decrease year-over-year.
  • Seres Therapeutics, Inc. total liabilities for 2025 were 94.0M, a 25.43% decrease from 2024.
  • Seres Therapeutics, Inc. total liabilities for 2024 were 126.0M, a 68.76% decrease from 2023.
  • Seres Therapeutics, Inc. total liabilities for 2023 were 403.5M, a 19.37% increase from 2022.
  • Seres Therapeutics, Inc. total liabilities for 2022 were 338.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Seres Therapeutics, Inc. Annual Total Liabilities (Millions of US $)
2025$94
2024$126
2023$403
2022$338
2021$223
2020$168
2019$181
2018$169
2017$129
2016$140
2015$12
Seres Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$94
2024-12-31$126
2023-12-31$403
2022-12-31$338
2021-12-31$223
2020-12-31$168
2019-12-31$181
2018-12-31$169
2017-12-31$129
2016-12-31$140
2015-12-31$12

Seres Therapeutics, Inc. Total Liabilities — FAQ

Seres Therapeutics, Inc. (MCRB) total liabilities over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MCRB's total liabilities history?

The chart and table above show Seres Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.